QHSLab (BST:E1Z) - Stock Price, News & Analysis

E1Z Stock Overview

A medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine.

About the company

E1Z fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	5/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Rewards

Earnings are forecast to grow 147.04% per year

Risk Analysis

Does not have a meaningful market cap (€2M)

Does not have meaningful revenue ($1M)

Shareholders have been diluted in the past year

Volatile share price over the past 3 months

QHSLab, Inc. Competitors

MagForce

XTRA:MF6

€3.6m

Audientes

DB:AUG

€6.9m

MagForce

DB:MF6

€366.9k

aap Implantate

XTRA:AAQ1

€13.4m

Price History & Performance

Summary of all time highs, changes and price drops for QHSLab
Historical stock prices
Current Share Price	US$0.22
52 Week High	US$0.31
52 Week Low	US$0.22
Beta	-4.57
11 Month Change	-20.43%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-22.68%

Recent updates

Shareholder Returns

	E1Z	DE Medical Equipment	DE Market
7D	-21.1%	12.7%	4.5%
1Y	n/a	9.1%	13.4%

Return vs Industry: Insufficient data to determine how E1Z performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how E1Z performed against the German Market.

Price Volatility

Is E1Z's price volatile compared to industry and market?
E1Z volatility
E1Z Average Weekly Movement	8.2%
Medical Equipment Industry Average Movement	5.2%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	11.6%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: E1Z's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine E1Z's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1983	5	Troy Grogan	www.usaqcorp.com

QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It also develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. In addition, the company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians.

QHSLab, Inc. Fundamentals Summary

How do QHSLab's earnings and revenue compare to its market cap?
E1Z fundamental statistics
Market cap	€2.16m
Earnings (TTM)	-€856.67k
Revenue (TTM)	€1.44m

1.5x

P/S Ratio

-2.5x

P/E Ratio

Is E1Z overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
E1Z income statement (TTM)
Revenue	US$1.47m
Cost of Revenue	US$739.56k
Gross Profit	US$725.86k
Other Expenses	US$1.60m
Earnings	-US$873.79k

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	-0.099
Gross Margin	49.53%
Net Profit Margin	-59.63%
Debt/Equity Ratio	209.1%

How did E1Z perform over the long term?

See historical performance and comparison

QHSLab BST:E1Z Stock Report